checkAd

     1152  0 Kommentare Biotech Is Fueling An All-New Cannabis Boom - Seite 2

    A New Path for Safe, Effective Treatments

    The start of this massive boom began in California, when they legalized medical marijuana with overwhelming support in 1996. Since then, dozens of other states and entire nations have jumped onboard…And the global cannabis industry is expected to reach an incredible $57 billion by 2025.

    That's helping to ease the suffering of countless people around the world struggling with conditions from migraines and chronic pain to cancer.In fact, in a breakthrough study, 92% of patients said that medical marijuana was helpful in alleviating their symptoms. But in this booming industry, there's been one huge problem.

    Anzeige 
    Handeln Sie Ihre Einschätzung zu AbbVie!
    Short
    196,10€
    Basispreis
    1,55
    Ask
    × 9,30
    Hebel
    Long
    165,36€
    Basispreis
    1,74
    Ask
    × 8,29
    Hebel
    Präsentiert von

    Den Basisprospekt sowie die Endgültigen Bedingungen und die Basisinformationsblätter erhalten Sie bei Klick auf das Disclaimer Dokument. Beachten Sie auch die weiteren Hinweise zu dieser Werbung.

    With federal laws still classifying medical marijuana as a Schedule I drug, it's stifled their ability to conduct the studies proving the incredible effects that individuals have been reporting for years. That's why Juva Life (JUVA; JUVAF) has aimed to create a very detailed database, unlocking a whole new world of opportunities. It's expected to be the first major database compiling data for proven, effective treatments in this long-overlooked area.

    So rather than going through a process that can cost up to $2.6 billion to develop a new treatment through the FDA...And can take up to a decade of time...Juva Life will use an IRB-approved process that could lead to effective treatments with just a fraction of the cost and time.

    But the most exciting part is that after they've compiled the data...Juva Life plans to use artificial intelligence (AI), proprietary software, and their team's collective decades of experience to create proprietary versions of the most effective, proven treatments.

    Already Driving Revenue - And the Pace is Picking Up

    With their new database set to open new opportunities, Juva Life (JUVA; JUVAF) has also been busy driving revenue through the other arm of their business.

    While it usually costs over $2 billion to develop new treatments the old way through the FDA...They are aiming to cut years, billions of dollars, and lots of risk out of the process because of the IRB-approved processes they can conduct their research through.

    Juva Life has pinpointed what they see as strategic holes in the market all around the San Francisco area, including retail and delivery services. And they opened operations in Redwood City and Stockton in 2020

    They've been delivering the best, most trusted products to the area for several months already…But soon, they plan on creating and distributing their own in-house brands.

    They've already received local approval to open their production facility shortly, and they're expected to be producing their own products within 6-8 months. The revenue Juva Life has already been able to drive from a secondary asset is important. Particularly during a year when many businesses have been shuttered due to the pandemic and government shutdowns.

    Seite 2 von 7


    PR Newswire (engl.)
    0 Follower
    Autor folgen

    Verfasst von PR Newswire (engl.)
    Biotech Is Fueling An All-New Cannabis Boom - Seite 2 NEW YORK, Jan. 21, 2021 /PRNewswire/ - On October 10, 1962, JFK signed into law a little-known act that helped put a massive $1.25 trillion industry on the map. And today, the trillion-dollar pharmaceutical industry is being pushed to make a shift.  …